Studies on BC have revealed that over-expression of TFPI-2 limits phosphorylation of EGFR/ERK1/2 and decreases pERK1/2 translocation into the nucleus, which results in a reduction in cell proliferation. The gene discussed is TFPI2; the disease is breast cancer.